160 related articles for article (PubMed ID: 15368473)
1. Trefoil factor 3 overexpression in prostatic carcinoma: prognostic importance using tissue microarrays.
Faith DA; Isaacs WB; Morgan JD; Fedor HL; Hicks JL; Mangold LA; Walsh PC; Partin AW; Platz EA; Luo J; De Marzo AM
Prostate; 2004 Nov; 61(3):215-27. PubMed ID: 15368473
[TBL] [Abstract][Full Text] [Related]
2. Trefoil factor 3 is overexpressed in human prostate cancer.
Garraway IP; Seligson D; Said J; Horvath S; Reiter RE
Prostate; 2004 Nov; 61(3):209-14. PubMed ID: 15368472
[TBL] [Abstract][Full Text] [Related]
3. Expression of trefoil factor family members correlates with patient prognosis and neoangiogenesis.
Dhar DK; Wang TC; Tabara H; Tonomoto Y; Maruyama R; Tachibana M; Kubota H; Nagasue N
Clin Cancer Res; 2005 Sep; 11(18):6472-8. PubMed ID: 16166422
[TBL] [Abstract][Full Text] [Related]
4. [Trefoil factor family gene and peptide expression in pterygium].
Lafontaine PO; Arnal M; Buron N; Solary E; Lizard S; Bron A; Bara J; Gespach C; Creuzot-Garcher C
J Fr Ophtalmol; 2003 Dec; 26(10):1007-14. PubMed ID: 14691392
[TBL] [Abstract][Full Text] [Related]
5. Trefoil factor 3 (TFF3) enhances the oncogenic characteristics of prostate carcinoma cells and reduces sensitivity to ionising radiation.
Perera O; Evans A; Pertziger M; MacDonald C; Chen H; Liu DX; Lobie PE; Perry JK
Cancer Lett; 2015 May; 361(1):104-11. PubMed ID: 25748388
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of trefoil factors are increased in patients with advanced prostate cancer.
Vestergaard EM; Borre M; Poulsen SS; Nexø E; Tørring N
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):807-12. PubMed ID: 16467092
[TBL] [Abstract][Full Text] [Related]
7. Expression of trefoil peptides in the subtypes of intestinal metaplasia.
Kim BW; Kim KM; Lee BI; Maeng LS; Choi H; Cho SH; Chae HS; Kim JK; Choi KY; Chung IS
Peptides; 2004 May; 25(5):779-83. PubMed ID: 15177872
[TBL] [Abstract][Full Text] [Related]
8. A gradient of TFF3 (trefoil factor family 3) peptide synthesis within the normal human gastric mucosa.
Kouznetsova I; Peitz U; Vieth M; Meyer F; Vestergaard EM; Malfertheiner P; Roessner A; Lippert H; Hoffmann W
Cell Tissue Res; 2004 May; 316(2):155-65. PubMed ID: 14968359
[TBL] [Abstract][Full Text] [Related]
9. Frequent trefoil factor 3 (TFF3) overexpression and promoter hypomethylation in mouse and human hepatocellular carcinomas.
Okada H; Kimura MT; Tan D; Fujiwara K; Igarashi J; Makuuchi M; Hui AM; Tsurumaru M; Nagase H
Int J Oncol; 2005 Feb; 26(2):369-77. PubMed ID: 15645121
[TBL] [Abstract][Full Text] [Related]
10. Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues.
Leung WK; Yu J; Chan FK; To KF; Chan MW; Ebert MP; Ng EK; Chung SC; Malfertheiner P; Sung JJ
J Pathol; 2002 Aug; 197(5):582-8. PubMed ID: 12210076
[TBL] [Abstract][Full Text] [Related]
11. Expression of intestinal trefoil factor in developing rat intestine.
Lin J; Holzman IR; Jiang P; Babyatsky MW
Biol Neonate; 1999 Aug; 76(2):92-7. PubMed ID: 10393993
[TBL] [Abstract][Full Text] [Related]
12. TFF peptides in the human efferent tear ducts.
Paulsen FP; Hinz M; Schaudig U; Thale AB; Hoffmann W
Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3359-64. PubMed ID: 12407144
[TBL] [Abstract][Full Text] [Related]
13. Trefoil factor family (TFF) expression in the mouse brain and pituitary: changes in the developing cerebellum.
Hinz M; Schwegler H; Chwieralski CE; Laube G; Linke R; Pohle W; Hoffmann W
Peptides; 2004 May; 25(5):827-32. PubMed ID: 15177878
[TBL] [Abstract][Full Text] [Related]
14. Expression of trefoil factor family 1, 2, and 3 peptide is augmented in hepatolithiasis.
Sasaki M; Ikeda H; Ohira S; Ishikawa A; Nakanuma Y
Peptides; 2004 May; 25(5):763-70. PubMed ID: 15177870
[TBL] [Abstract][Full Text] [Related]
15. Localization of TFF3, a new mucus-associated peptide of the human respiratory tract.
Wiede A; Jagla W; Welte T; Köhnlein T; Busk H; Hoffmann W
Am J Respir Crit Care Med; 1999 Apr; 159(4 Pt 1):1330-5. PubMed ID: 10194185
[TBL] [Abstract][Full Text] [Related]
16. Trefoil factor family mRNA and protein expression in pterygium.
Lafontaine PO; Arnal M; Buron N; Solary E; Bron AM; Westley BR; May FE; Bara J; Gespach C; Creuzot-Garcher C
Int J Oncol; 2005 Oct; 27(4):997-1003. PubMed ID: 16142316
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of high mobility group box 1 with poor prognosis in patients after radical prostatectomy.
Li T; Gui Y; Yuan T; Liao G; Bian C; Jiang Q; Huang S; Liu B; Wu D
BJU Int; 2012 Dec; 110(11 Pt C):E1125-30. PubMed ID: 22672360
[TBL] [Abstract][Full Text] [Related]
18. 8q24 amplification is associated with Myc expression and prostate cancer progression and is an independent predictor of recurrence after radical prostatectomy.
Fromont G; Godet J; Peyret A; Irani J; Celhay O; Rozet F; Cathelineau X; Cussenot O
Hum Pathol; 2013 Aug; 44(8):1617-23. PubMed ID: 23574779
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of SUMO-specific protease 1 (SENP1) in prostate cancer patients undergoing radical prostatectomy.
Li T; Huang S; Dong M; Gui Y; Wu D
Urol Oncol; 2013 Nov; 31(8):1539-45. PubMed ID: 23089540
[TBL] [Abstract][Full Text] [Related]
20. Stromal cell-derived factor-1 and vascular endothelial growth factor as biomarkers for lymph node metastasis and poor cancer-specific survival in prostate cancer patients after radical prostatectomy.
Wang Q; Diao X; Sun J; Chen Z
Urol Oncol; 2013 Apr; 31(3):312-7. PubMed ID: 21367627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
